Excelmab
Focus: Excelmab is a China-based biotechnology company specializing in bispecific antibody platform technology. The company operates from Guangzhou and focuses on advanced antibody engineering.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Excelmab
AI assessmentNot HiringNo open roles listed right now. Follow Excelmab to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
EX103 injection
CD20-positive Non-Hodgkin LymphomaClinical Trials (1)
NCT06021678Safety and Efficacy of EX103 in Subjects with Relapsed/Refractory CD20-Positive Non-Hodgkin Lymphoma
Phase 1/2Help build intelligence for Excelmab
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.